S. 954 — 118th Congress
Federal bill
Affordable Insulin Now Act of 2023
- Title
- Affordable Insulin Now Act of 2023
- Official title
- A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals.
- Type
- Senate bill
- Congress
- 118th Congress
- Chamber of origin
- Senate
- Introduced
- 2023-03-23
- Latest action
- Committee on Banking, Housing, and Urban Affairs. Hearings held. Hearings printed: S.Hrg. 118-511.
- Latest action date
- 2023-11-30
Organizations that named this bill in federal lobbying filings
- NFIB (NATIONAL FEDERATION OF INDEPENDENT BUSINESS) Federal lobbying client (LDA)
- AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) Federal lobbying client (LDA)
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA Federal lobbying client (LDA)
- PUBLIC CITIZEN Federal lobbying client (LDA)
- THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) Federal lobbying client (LDA)
Federal lobbying filings naming this bill
U.S. Senate Lobbying Disclosure Act database. A filing names bills, issues and agencies — never the member lobbied — so these rows point only at the client organization, and none of them says any member of Congress was lobbied about this bill. The count is filings in this site's LDA slice, not the
- NFIB (NATIONAL FEDERATION OF INDEPENDENT BUSINESS) cited in the filing's issue text 6 filings
- AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) cited in the filing's issue text 2 filings
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA cited in the filing's issue text 2 filings
- PUBLIC CITIZEN cited in the filing's issue text 2 filings
- THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) cited in the filing's issue text 1 filing